Y-L Yu

Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a cohort study

J. Staessen, H. Mischak, L. Thijs, 2022, medRxiv.

A study of CCND1 with epithelial ovarian cancer cell proliferation and apoptosis.

R. Li, J. Dai, J.-B. Feng, 2016, European review for medical and pharmacological sciences.

Targeting post-translational modifications of histones for cancer therapy.

R. Chou, Y. Hsieh, Y-L Yu, 2015, Cellular and molecular biology.

The effect of DC+CIK combined therapy on rat liver cancer model and its modulatory effect on immune functions.

B. Wang, Z. Huang, S. Zhou, 2018, European review for medical and pharmacological sciences.